Clinical trial
Safety and Efficacy Assessments of Osalmid in the Treatment of Multiple Myeloma
NCT03670173 is registered in ClinicalTrials.gov with Shanghai 10th People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy Assessments of Osalmid in the Treatment of Multiple Myeloma
- Lead sponsor
- Shanghai 10th People's Hospital
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- October 1, 2018
- Completion date
- May 18, 2021
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.